Submitted:
30 October 2023
Posted:
31 October 2023
You are already at the latest version
Abstract
Keywords:
1. INTRODUCTION
2. MATERIAL AND METHODS
2.1. Study design and setting
2.2. Data and sample collection
2.3. Statistical analysis
3. RESULTS
4. DISCUSSION
Author Contributions
Acknowledgments
Data Availability Statement
Conflicts of Interest
References
- Shi J, Liu Y, Liu Y, et al. Association between ApoE polymorphism and hypertension: A meta-analysis of 28 studies including 5898 cases and 7518 controls. Gene. 2018, 675, 197–207.
- Wyatt CM, Chertow GM. Updated guidelines for the diagnosis and management of high blood pressure: implications for clinical practice in nephrology. Kidney Int. 2018, 93, 768–70.
- Vetrano DL, Calderón-Larrañaga A, Marengoni A, et al. An International Perspective on Chronic Multimorbidity: Approaching the Elephant in the Room. The Journals of Gerontology: Series A. 2018, 73, 1350–1356.
- Singer, P.S. Updates on Hypertension and New Guidelines. Adv Pediatr 2019, 66, 177–187. [Google Scholar] [CrossRef]
- Wu W, Diao J, Yang J, et al. Impact of Sociodemographic Characteristics, Lifestyle, and Obesity on Coexistence of Diabetes and Hypertension: A Structural Equation Model Analysis amongst Chinese Adults. Int J Hypertens. 2021, 2021, 1–12.
- Riley L, Guthold R, Cowan M, et al. The World Health Organization STEPwise Approach to Noncommunicable Disease Risk-Factor Surveillance: Methods, Challenges, and Opportunities. Am J Public Health. 2016, 106, 74–78.
- Pires JE, Sebastião Y V, Langa AJ, Nery S V. Hypertension in Northern Angola: prevalence, associated factors, awareness, treatment and control. BMC Public Health. 2013, 13, 90.
- Paquissi FC, Cuvinje ABP, Cuvinje AB, Paquissi AM. Hypertension among Outpatients at a General Hospital in South Angola: Prevalence, Awareness, Treatment, and Control. Clin Med Insights Cardiol. 2016, 10, CMCS39561.
- Sebastião CS, Sacomboio E, Francisco NM, et al. Blood pressure pattern among blood donors exposed to SARS-CoV-2 in Luanda, Angola: A retrospective study. Health Sci Rep. 2023, 6.
- Sebastião CS, Sacomboio E, Francisco NM, et al. Demographic characteristics and risk factors related to high blood pressure among healthy blood donors from Luanda, Angola: A retrospective study. Health Sci Rep. 2023, 6.
- Gatimu SM, John TW. Socioeconomic inequalities in hypertension in Kenya: a decomposition analysis of 2015 Kenya STEPwise survey on non-communicable diseases risk factors. Int J Equity Health [Internet]. 2020; 19. Available online: https://pubmed.ncbi.nlm.nih.gov/33267846/ (accessed on 5 October 2023).
- Fonseca-Reyes S, Forsyth-MacQuarrie AM, García de Alba-García JE. Simultaneous blood pressure measurement in both arms in hypertensive and nonhypertensive adult patients. Blood Press Monit. 2012, 17, 149–154.
- Vischer AS, Burkard, T. Principles of Blood Pressure Measurement – Current Techniques, Office vs Ambulatory Blood Pressure Measurement. 2016; 85–96.
- Shi J, Liu Y, Liu Y, et al. Association between ApoE polymorphism and hypertension: A meta-analysis of 28 studies including 5898 cases and 7518 controls. Gene. 2018, 675, 197–207.
- Parati G, Lackland DT, Campbell NRC, et al. How to Improve Awareness, Treatment, and Control of Hypertension in Africa, and How to Reduce Its Consequences: A Call to Action from the World Hypertension League. Hypertension [Internet]. 2022, 79, 1949–1961. Available online: https://pubmed.ncbi.nlm.nih.gov/35638381/ (accessed on 2 October 2023).
- Zatońska K, Basiak-Rasała A, Połtyn-Zaradna K, et al. Sociodemographic and behavioral factors associated with controlled hypertension after 9 years of observation of a PURE Poland cohort study. Front Public Health. 2023, 11.
- Oliveira GF, Marin TC, Forjaz CLM, Brito LC. Exercise Training and Endothelial Function in Hypertension: Effects of Aerobic and Resistance Training. Arq Bras Cardiol [Internet]. 2021, 116, 948–949. Available online: https://pubmed.ncbi.nlm.nih.gov/34008819/ (accessed on 2 October 2023).
- Moussouni A, Sidi-yakhlef A, Hamdaoui H, Aouar A, Belkhatir, D. Prevalence and risk factors of prehypertension and hypertension in Algeria. BMC Public Health [Internet]. 2022; 22. Available online: https://pubmed.ncbi.nlm.nih.gov/35982441/ (accessed on 4 October 2023).
- Mendy VL, Vargas R, Ogungbe O, Zhang, L. Hypertension among Mississippi Workers by Sociodemographic Characteristics and Occupation, Behavioral Risk Factor Surveillance System. Int J Hypertens [Internet] 2020. 2020. Available online: https://pubmed.ncbi.nlm.nih.gov/32724672/ (accessed on 2 October 2023).
- Pedro JM, Brito M, Barros, H. Cardiovascular Risk Assessment in Angolan Adults: A Descriptive Analysis from CardioBengo, a Community-Based Survey. Int J Hypertens. 2018, 2018, 1–6.
| Independent variables | N (%) | Hypertension | Univariate analysis | |||
|---|---|---|---|---|---|---|
| No (%) | Yes (%) | p-value | OR (95% CI) | p-value | ||
| Overall | 158 (100) | 52 (32.9) | 106 (67.1) | |||
| Demographic characteristic | ||||||
| Age, year (mean ± SD) | 54.9 ± 12.0 | 53.1 ± 13.4 | 55.8 ± 11.3 | 0.199 | ||
| Age distribution | ||||||
| <30 yo | 3 (1.90) | 1 (1.90) | 2 (1.90) | 0.079 | 0.41 (0.30 – 5.28) | 0.493 |
| 30 – 40 yo | 20 (12.7) | 11 (21.2) | 9 (8.50) | 1.19 (0.11 – 13.5) | 0.890 | |
| >40 yo | 135 (85.4) | 40 (76.9) | 95 (89.6) | 1.00 | ||
| Gender | ||||||
| Female | 107 (67.7) | 34 (65.4)) | 73(68.9) | 1.00 | ||
| Male | 51 (32.7) | 18 (34,6) | 33 (31.1) | 0.660 | 1.17 (0.58 – 2.37) | 0.660 |
| Occupation | ||||||
| Unemployed | 104 (65.8) | 34 (65,4) | 70 (66,0) | 1.00 | ||
| Employed | 54 (34,2) | 18 (34.6) | 36 (34.0) | 0.935 | 9.94 (0.48 – 1.95) | 0.935 |
| Residence area | ||||||
| Non-Urbanized | 28 (17.7) | 8 (15.4) | 20(18,9) | 0.590 | 1.00 | |
| Urbanized | 130 (82.3) | 44 (84.6) | 86 (81.1) | 0.78 (0.32 – 1.92) | 0.591 | |
| Educational level | ||||||
| Illiterate | 16 (10.1) | 4 (10.5) | 12 (16,9) | 0.359 | 0.43 (0.12 – 1.55) | 0.194 |
| Basic | 41 (25.9) | 18(34.6) | 23(21.7) | 0.75 (0.21 – 2.69) | 0.658 | |
| Medium | 52 (32.9) | 16 (30.8) | 36 (34.0) | 0.83 (0.23 – 3.03) | 0.782 | |
| High | 52 (47.7) | 16 (42.1) | 36 (50.7) | 1.00 | ||
| Behavioural characteristic | ||||||
| Alcohol | ||||||
| No | 145 (91.8) | 48 (92.3) | 97 (91.5) | 0.864 | 1.00 | |
| Yes | 13 (8.20) | 4 (7.70) | 9 (8.50) | 1.11 (0.33 – 3.80) | 0.864 | |
| Physic activity | ||||||
| No | 70 (44.3) | 24 (46.2) | 46 (43.4) | 0.743 | 1.00 | |
| Yes | 88 (55.7) | 28 (53.8) | 60 (56.6) | 1.12 (0.57 – 2.18) | 0.743 | |
| Clinical characteristics | N (%) | Hypertension | ||
|---|---|---|---|---|
| No (%) | Yes (%) | p-value | ||
| Overall | 158 (100) | 52 (32.9) | 106 (67.1) | |
| Signal and symptoms | ||||
| Headache | 122 (77,2) | 41 (78.8) | 81 (76.4) | 0.732 |
| Chest pain | 36 (22.8) | 11 (21.2) | 25 (23.6) | 0.723 |
| Blurry vision | 117 (74,1) | 36 (69.2) | 81 (76.4) | 0.333 |
| Buzz | 92 (58.2) | 29 (55.8) | 63 (59.4) | 0.661 |
| Nosebleed | 145 (91.8) | 48 (92.3) | 97 (91.8) | 0.864 |
| Asthenia | 141 (89.2) | 44 (84.6) | 97 (91,5) | 0.189 |
| Comorbidities | ||||
| No | 53 (33.5) | 17 (32.7) | 36 (34.0) | 0.874 |
| Yes | 105 (66.5) | 35 (67.3) | 70 (66.0) | |
| Distribution Comorbidities | ||||
| AVC | 9 (5.70) | 3 (5.80) | 6 (5.70) | 0.978 |
| Heart failure | 48 (30.4) | 17 (32.7) | 31 (29.2) | 0.658 |
| Arterial injury | 30 (19.0) | 9 (17.3) | 21 (19.8) | 0.706 |
| Retinal damage | 15 (9.50) | 97 (91.5) | 9 (8.50) | 0.539 |
| Aneurysm | 1 (0.90) | 0 (0.00) | 1 (0.90) | 0.482 |
| Angina Pectoris | 1 (0.60) | 0 (0.00) | 1 (0.90) | 0.482 |
| Body mass index | ||||
| Normal | 40 (25,3) | 17 (32.7) | 23 (21.7) | 0.011 |
| Overweight | 62 (39.2) | 25 (48.1) | 37 (34.9) | |
| Obesity | 56 (35.4) | 10 (19.2) | 46 (43.4) | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).